GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,112,000 | -7.8% | 160,000 | 0.0% | 5.11% | +167.6% |
| Q1 2022 | $5,542,000 | +18.3% | 160,000 | 0.0% | 1.91% | -47.2% |
| Q4 2021 | $4,683,000 | +14.9% | 160,000 | 0.0% | 3.62% | -12.6% |
| Q3 2021 | $4,077,000 | -13.8% | 160,000 | +18.5% | 4.14% | +21.2% |
| Q2 2021 | $4,728,000 | +65.7% | 135,000 | +92.9% | 3.42% | +93.2% |
| Q1 2021 | $2,853,000 | +176.7% | 70,000 | +7.7% | 1.77% | +188.9% |
| Q1 2016 | $1,031,000 | – | 65,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |